Mersana announces management changes

09/29/2010 | Mass High Tech (Boston)

Mersana Therapeutics has selected Nicholas Bacopoulos, a biotech industry veteran who has been on the company's board since 2007, to serve as its president and chief executive. The company, which uses a bio-inert polymer technology in drug development, also has appointed its former CEO Julie Olson as chief technology officer.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA